Abstract: Expression of phosphatidylserine (PS) on the surface of both macrophages and their apoptotic targets is required for efficient phagocytosis. Monocytes, the precursors of macrophages, do not express PS on their surface and do not efficiently phagocytose apoptotic cells. We report here that PS appears on the surface of both human monocytic U937 cells and primary human monocytes as they differentiate in culture and acquire the ability to phagocytose apoptotic thymocytes. Phagocytosis was blocked by pretreating either the apoptotic target or the phagocyte with annexin V to mask PS and was CD14-dependent. Expression of PS, like other events characteristic of differentiating monocytes such as Mac-1 expression, was independent of the agent used to induce differentiation and was insensitive to the addition of caspase inhibitors. These results demonstrate that PS is expressed on monocytes as part of their differentiation program and is independent of apoptosis. J. Leukoc. Biol. 74: 846 -856; 2003.
INTRODUCTION
Although a wide variety of macrophage receptors have been implicated in the clearance of apoptotic cells, very few ligands have been identified on the apoptotic cell surface [1] . Of these few, the most widely recognized is phosphatidylserine (PS). This phospholipid is normally restricted to the inner leaflet of the plasma membrane by inwardly directed, energy-dependent transport [2] . Thymocytes undergoing apoptosis down-regulate this transport and activate a lipid scramblase, which equilibrates the lipids in the two leaflets of the membrane, bringing PS to the cell surface [3] . PS on the cell surface serves as a ligand, because PS vesicles [4] or erythrocytes with PS expressed on their surface [5] stereospecifically inhibit the phagocytosis of apoptotic thymocytes by macrophages. In addition, pretreating apoptotic target cells with annexin V, which specifically binds and masks PS, blocks phagocytosis [6] .
Loss of phospholipid asymmetry and exposure of PS on the apoptotic cell surface is not only necessary, but also sufficient, to engage a number of macrophage receptors implicated in recognition of apoptotic cells. Elevating cytosolic Ca 2ϩ levels using ionophore activates the scramblase and brings PS to the surface of thymocytes in a matter of minutes [7] . Phagocytosis of these targets is inhibited by PS vesicles, annexin V, the tetrapeptide RGDS, N-acetylglucosamine, and monoclonal antibody 61D3 [8, 9] , suggesting that a PS receptor, an integrin, a lectin-like receptor and CD14 on the macrophage surface are all engaged by these targets. Because such a short treatment with ionophore does not leave time for gene expression or protein synthesis to generate new ligands on the target cell surface, abolition of phospholipid asymmetry may induce conformational changes in or rearrange pre-existing membrane proteins, exposing new recognition epitopes [9] . Unexpectedly, recent results suggest that PS expression is required not just on the target cell surface, but also on the macrophage that engulfs the apoptotic cell. Unlike virtually all normal, healthy cells, macrophages appear to constitutively exhibit at least a partial loss of lipid asymmetry [10] and associated PS expression [8, 11] . When macrophages are pretreated with annexin V to mask this surface PS, inhibition of phagocytosis is just as efficient as when apoptotic thymocytes are pretreated [8, 11] . On the other hand, monocytes, the precursors of macrophages, do not express PS on their surface: monocytes drawn from the circulation maintain an asymmetric distribution of phospholipids [12] and do not bind annexin V [13] . As might be expected, freshly isolated human monocytes are unable to engulf PS-expressing apoptotic cells [14, 15] , whereas in vitro maturation to macrophages enables phagocytosis of erythrocytes with PS on their surface [16] and apoptotic target cells [5, 14] . In the present study, we have used a human monocytic cell line, as well as primary human monocytes, to explore in more detail the relationship between the acquisition of expression of PS on the phagocyte cell surface and the phagocytosis of apoptotic thymocytes. Several human monocytic cell lines can be induced to differentiate with PMA, and at least one line (THP-1) has been reported to acquire the ability to phagocytose apoptotic cells in a manner inhibitable by PS vesicles [14, 15] , just as primary macrophages. However, whether differentiation induces the expression of PS on the surface of such cells, and if so, whether that PS expression is required for phagocytosis of apoptotic cells, has not been examined.
It was recently reported that the differentiation of U937 cells to macrophages induced by treatment with phorbol esters is accompanied by changes normally associated with apoptosis, including nuclear fragmentation and chromatin condensation, DNA fragmentation, mitochondrial cytochrome C release, and activation of caspase-3 [17] . All of the events could be blocked by the broad-spectrum caspase inhibitor zVAD-fmk, leading to the suggestion that in these cells the processes of terminal differentiation and apoptosis are related. U937 cells therefore provide an opportunity to investigate not only PS expression on differentiating monocytic cells and its relationship to the ability to phagocytose apoptotic cells, but also its relationship to the mechanisms that lead to PS expression on apoptotic cells. Here, we demonstrate that differentiation of U937 cells, just like their primary monocyte counterparts, is associated with expression of PS on the cell surface, even in the presence of caspase inhibitors. More important, this surface PS is required for phagocytosis of apoptotic thymocytes, just as for primary macrophages.
MATERIALS AND METHODS

Materials
Dexamethasone, propidium iodide (PI), FITC-conjugated rabbit anti-murine IgG antibody, phorbol myristate acetate (PMA), fetal bovine serum (FBS), mouse IgG 2 isotype control (clone MOPC 141), anti-murine CD14 IgG (clone UCHM1) and poly-L-lysine hydrobromide were purchased from Sigma Chemical Company (St. Louis, MO), Diff-Quik staining reagents from Baxter Science Products (McGaw, IL), Leu-M3 anti-CD14 mAb from Becton Dickinson (Franklin Lakes, NJ), caspase inhibitor I (zVAD-fmk) from Calbiochem Novabiochem Corp. (San Diego, CA), camptothecin (CAM) from ICN Biotech (Irvine, CA), Suicide-Track TM DNA Ladder Isolation kit from Oncogene Research Products (Cambridge, MA), Pellet Paint TM coprecipitant from Novagen (Madison, WI), all-trans-retinoic acid (t-RA) and 1,25␣ dihydroxyvitaminD3 (VitD3) from EMD Biosciences (Calbiochem), U937 monocytic cells from American Type Culture Collection, and fluoresceinated latex beads (1 m in diameter) from Polysciences. Phycoerythrin (PE)-conjugated annexin V, PEconjugated anti-CD11b (clone ICRF44), PE-conjugated anti-CD14 (clone M5E2), and PE-conjugated murine IgG 2a and IgG 1 isotype controls (clones MOPC-21 and G155-178) were purchased from PharMingen, FITC-conjugated annexin V from Molecular Probes, and Ficoll-Paque TM from AmershamPharmacia Biotech (Piscataway, NJ). Unlabeled annexin V was purified as described previously in detail [6, 18] .
Monocytes and macrophages
U937 cells were cultured in RPMI 1640 medium supplemented with 2 mM glutamine and 10% FBS at 37°C in 5% CO 2 . Apoptosis was induced in log phase U937 cells by culturing for 3 h with 4 g/ml of CAM. Log phase U937 cells were induced to differentiate by culturing for 24Ϫ72 h with 10 ng/ml of PMA or by culturing for 72Ϫ168 h with either 100 nM VitD3 or 1 M t-RA alone, or in combination. In some experiments, U937 cells were preincubated for 30 min in medium containing 10 M zVAD-fmk, then PMA or CAM added directly to the cultures as above. Human monocyte-derived macrophages (HMDM) were prepared from fresh human venous blood obtained from volunteers according to institutional guidelines [19] . Blood was collected into ice-cold PBS (7.4 mM Na 2 HPO 4 , 2.6 mM NaH 2 PO 4 , 137 mM NaCl, 10 mM KCl) containing 10 U/ml of heparin, and centrifuged at 278 ϫ g for 5 min. The buffy coat and top 10% of erythrocytes were removed and diluted 1:2 with PBS. Mononuclear cells in the suspension were separated by centrifugation on Ficoll-Paque, according to the manufacturer's instructions. After culturing at 37°C for 2 h (0-day cultures) or overnight in RPMI 1640 medium containing 10% FBS, medium and nonadherent cells were removed by aspiration. Fresh medium was added to long-term cultures and changed approximately every 3 days. Monocytes in 0-day cultures were identified by flow cytometry based on their characteristic high forward angle light scatter (FS) and intermediate side-angle light scatter (SS) [20] . In long-term cultures, HMDM were identified by their high FS and SS characteristics and were easily distinguished from monocytes.
Thymocytes
Male CBA/J mice, 4Ϫ8 wk of age, were maintained on food and water ad libitum in accordance with the guidelines of the Institutional Animal Care and Use Committee. Thymuses were removed and dissociated in PBS. After collecting cells by centrifugation and resuspending in 17 mM Tris, 140 mM NH 4 Cl, pH 7.2, to lyse erythrocytes, thymocytes were washed and resuspended at 10 6 cells/ml in RPMI 1640 medium containing 10% FBS. Apoptosis was induced by incubation at 37°C in 5% CO 2 for 6 h in the presence of 10 Ϫ6 M dexamethasone.
61D3 mAb
61D3 hybridoma cells were a gift from Dr. Donald Capra, Oklahoma Medical Research Foundation, Oklahoma City, OK. 61D3 cells were grown to ϳ10 7 cells/ml in medium supplemented with IgG-deficient FBS. After removing the cells by centrifugation, 61D3 mAb was purified from the supernatant by Protein-A chromatography, according to the manufacturer's instructions (BioRad).
Annexin V and antibody staining
Adherent monocytes, HMDM, and U937 cells were collected by scraping them into buffer. 1 ϫ 10 6 cells were incubated with 5 l of PE-annexin V or FITC-annexin V in 100 L of annexin V buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ), according to the manufacturer's instructions. After 15 min on ice, 400 l of ice-cold annexin V buffer and, in some experiments, 5 l of a 1 mg/ml solution of PI was added, and the cells analyzed by flow cytometry. As a negative control for all annexin V staining procedures, cells were washed extensively in Ca 2ϩ -free PBS and stained with annexin V in the absence of Ca 2ϩ . For antibody staining, cells were resuspended at 10 7 cells/ml in ice-cold staining buffer (PBS containing 1% FBS). For direct immunofluorescence, 100 l of cells was added to the volume of mAb or isotype control antibody specified by the manufacturer. For indirect immunofluorescence, 1 g of either 61D3 mAb or isotype control (clone MOPC 141) was added to 100 l of cells. After 25 min on ice, the cells were washed and 1 g of FITC-conjugated anti-murine IgG added. All samples labeled with antibody were washed in staining buffer after 25 min on ice and cells resuspended in 500 l of staining buffer for flow cytometric analysis.
Flow cytometry
Approximately 10,000 cells/sample were analyzed using an EPICS-XL-MCL flow cytometer (Coulter Electronics) fitted with a single 15 mW argon ion laser providing excitation at 488 nm. Cells stained with FITC were monitored through a 525-nm bandpass filter, and cells stained with PE or macrophages phagocytosing fluorescent latex beads were monitored through a 575-nm bandpass filter. As presented in Results, late apoptotic and dead U937 cells had the same decreased FS and increased SS characteristics, and both were gated out of all staining profiles. For both primary monocytes and HMDM, PI-positive cells were gated out of all profiles.
DNA fragmentation analysis
PMA-treated U937 cells were scraped into overlying medium. 4Ϫ5 ϫ 10 5 of these cells or untreated U937 cells were collected by centrifugation, the supernatant removed and genomic DNA extracted and fractionated into highmolecular-weight (HMW) and low-molecular-weight (LMW) fractions using the Suicide-Track DNA Ladder Isolation kit, according to the manufacturer's instructions. The entire content of each LMW sample was electrophoresed in a single lane of a 1.5% agarose TAE gel at 4Ϫ5 V/cm. The gel was then stained with 0.5 g/ml of ethidium bromide for 30 min, destained in 1 mM MgSO 4 , and DNA was visualized by UV light.
Phagocytosis assays
Nonadherent U937 cells were plated onto glass 16-well microchamber slides preincubated for 5 min at room temperature with 100 l/well of 0.1 mg/ml of poly-L-lysine prepared in sterile H 2 O and then washed with sterile H 2 O. 3 ϫ 10 5 cells/well were incubated in annexin V buffer for 1Ϫ2 h prior to phagocytosis assays to permit cell adherence. Primary mononuclear cells were plated directly onto 18-mm coverslips. After 2 h incubation at 37°C, nonadherent cells were removed by aspiration, and adherent cells were washed once with ice-cold annexin V buffer. Adherent HMDM and U937 cells were released from culture dishes by scraping, and ϳ3 ϫ 10 5 cells in annexin V buffer were pipetted onto 18-mm bicarbonate-treated glass coverslips kept in 30 mm petri dishes. For all assays, 10 6 thymocytes in 150 l of annexin V buffer were overlaid onto 3 ϫ 10 5 macrophages. In some experiments, either the target cells or macrophages were first incubated in 150 l of annexin V buffer containing 10 M annexin V for 15 min at room temperature and then washed twice with annexin V buffer before targets overlaid onto macrophages. In other experiments, macrophages were pretreated with either 5 g of Leu-M3 anti-CD14 mAb or 5 g of 61D3 anti-CD14 mAb in 150 l of annexin V buffer for 15 min at room temperature before being overlaid with target cells. After 30 min at 37°C in 5% CO 2 for phagocytosis by HMDM, or 1 h for phagocytosis by U937 cells, coverslips were washed vigorously in annexin V buffer and fixed in 1.8% formaldehyde for 15 min before staining with Diff-Quik. The number of cells phagocytosed was enumerated as described in detail [5] . Results are presented as the mean ϩ/Ϫ standard deviation of triplicate coverslips. For phagocytosis of fluorescent latex beads, beads were washed twice in RPMI 1640 medium and resuspended in annexin V buffer at a 10,000-fold dilution, then 100 l was added to 3 ϫ 10 5 macrophages per well of a 24-well tissue culture plate that either had or had not been pretreated for 10 min with 200 l of either 1 M annexin V or BSA at room temperature. After 30 min at 37°C in 5% CO 2 , macrophages were washed and released from the dishes with 0.5 mM EDTA in PBS and analyzed by flow cytometry.
RESULTS
Apoptosis of U937 monocytic cells is associated with PS exposure that is caspase-dependent
To define the characteristics of U937 cells undergoing apoptosis, cells were treated with the topoisomerase inhibitor camptothecin (CAM) to induce apoptosis [21] . When analyzed by flow cytometry at 0 h, a small number of cells in the late phase of spontaneous apoptosis were detected by their altered light scatter characteristics due to cell shrinkage. Fig. 1A shows this subpopulation of shrunken, late apoptotic cells (R1) with reduced forward angle light scatter (FS) and increased side angle light scatter (SS) at 2 h after CAM treatment, after which time the number of cells in the subpopulation begins to increase (Fig. 1B) . Although the R1 subpopulation also includes lysed, dead cells, which stain with PI, the fraction of these cells in the R1 subpopulation does not increase with time, never exceeding 50% (not shown). As shown in Fig. 2 , laddered DNA typical of apoptotic cell death was clearly evident by 3 h of treatment. As expected, apoptosis also induced PS exposure. When cells treated with CAM for 3 h were stained with annexin V, all cells in the R1 subpopulation that excluded PI bound up to 30-fold more annexin V than normal cells (not shown), implying that PS exposure precedes shrinkage. When this annexin V-positive R1 subpopulation was gated out of the profile (Fig. 1C , middle panel), a prominent subpopulation of cells exhibiting increased annexin V staining was still evident, relative to untreated cells (Fig. 1C, top panel) . These annexin-V positive cells represent apoptotic cells with normal light scatter characteristics, confirming that PS exposure is a relatively early event, which precedes cell shrinkage. Given the central role of caspases in the induction and execution of the cell death program, their role in U937 cell apoptosis was examined using the broad-spectrum caspase inhibitor zVADfmk. As shown in Fig. 1C (lower panel), zVAD-fmk prevented the appearance of the subpopulation of cells with normal light scatter characteristics that expressed high levels of PS; it also prevented the increase in the R1 subpopulation (not shown). Finally, zVAD-fmk completely blocked DNA fragmentation induced by CAM (Fig. 2) .
Differentiation of U937 cells induced by PMA is associated with PS exposure that is not caspase-dependent
The characteristics of U937 cells undergoing apoptosis are in contrast to the alterations that occur when U937 cells are treated with PMA to induce differentiation, and are on a very different timescale. Untreated U937 cells are small, round, nonadherent cells that grow in suspension. After one day of treatment with PMA, the majority of U937 cells increase, rather than decrease, in size, become adherent, and assume an amoeboid appearance, alterations characteristic of maturation from monocytes to macrophages and not CAM-induced apo- ptosis. However, by 3Ϫ4 days of treatment with PMA, U937 cells exhibit membrane blebbing, are not as tightly adherent, and begin to lose membrane integrity, which are alterations characteristic of cells undergoing apoptosis. To monitor the timecourse of U937 cell differentiation, Mac-1 expression was measured. This CD11b/CD18 integrin receptor for complement is expressed at very low levels on monocytes [22] , including U937 monocytic cells [23, 24] , whereas macrophages, including U937 cells treated with PMA [23] , express high levels. As shown in Fig. 3A , untreated U937 cells express little to no Mac-1. However, after one day of treatment with PMA, Mac-1 was expressed (Fig. 3B) ; expression further increased by 2 days (Fig. 3C) and remained at this level after 3 days of treatment.
To determine whether these features of differentiation were dependent on caspase activation, cells induced with PMA were treated with zVAD-fmk. The changes in morphology characteristic of differentiating U937 cells occurred normally in the presence of the inhibitor (data not shown). In addition, zVADfmk treatment failed to prevent the increase in expression of Mac-1, as shown in Fig. 3D where zVAD-fmk-treated and untreated cells are compared at day 1 of PMA treatment. These results indicate that these features of PMA-induced U937 differentiation are not dependent on caspases. Previous studies by others [17] indicated that apoptosis-like events induced by PMA could be prevented by zVAD-fmk. To confirm these results and to ensure that the zVAD-fmk treatment was effective, cells induced to differentiate with PMA were examined for the generation of fragmented, laddered DNA. As shown in Fig.  2 , low-molecular-weight DNA was consistently detected after one or two days of treatment with PMA; however, the amounts generated were small and a faint laddering pattern was seen in only one of five separate experiments. The appearance of this low-molecular-weight DNA was consistently prevented by addition of zVAD-fmk, as previously reported [17] .
Collectively, these results indicate that although inhibition of caspase activity in differentiating U937 cells may block events characteristic of apoptosis, it has no effect on the morphological changes, or on the regulation of expression of cell surface molecules such as Mac-1.
Binding of annexin V was used to investigate whether the differentiation of U937 cells entails changes in expression of PS on the cell surface. Because apoptotic cells in the population will express PS irrespective of their differentiation status, the presence of these cells was monitored by measurement of light scatter characteristics as described for Fig. 1 . As shown in the insets to Fig. 4 , the low level of apoptotic cells in a normal population (3.9%) is increased somewhat by PMA treatment (5.9%), and this increase is reduced by treatment with zVADfmk (5.1%). As expected, these cells are all annexin-positive (data not shown). When these cells were gated out, the remaining viable cells nearly all displayed a 2.5-to threefold increase in median fluorescence after 2 days of treatment with PMA ( Fig. 4B) relative to untreated cells (Fig. 4A) . By comparison, the median increase in fluorescence was only ϳ1.5-fold after one day of PMA treatment (not shown). Unlike the case of PS expression on U937 cells treated with CAM to induce apoptosis, zVAD-fmk did not prevent the expression of PS on cells treated with PMA (Fig. 4C) .
PS on differentiated U937 cells is necessary for phagocytosis of apoptotic thymocytes
Previous studies indicate that the PS constitutively expressed on the surface of macrophages is required for phagocytosis of apoptotic thymocytes [8, 11] 
Such assays are most often performed with phagocytes in monolayer culture, whereas undifferentiated U937 cells are nonadherent. This complication was overcome by attaching the cells to polylysine-coated coverslips for phagocytosis assays [15] . Monolayers of these cells, or of the more adherent cells obtained after PMA treatment, were then overlaid with targets. When untreated U937 cells were presented with apoptotic murine thymocytes for 30 min, phagocytosis was negligible (data not shown). However, U937 cells cultured with PMA for one day acquired the ability to phagocytose apoptotic thymocytes (Fig. 5) , with levels of phagocytosis remaining constant or increasing somewhat after two days of PMA treatment. To exclude the possibility that attachment via polylysine inhibits phagocytosis of these PS-expressing targets, U937 cells treated for 2 days with PMA were removed from the culture dish and attached to polylysine-coated coverslips. Phagocytosis of apo- ptotic thymocytes by these U937 cells was not significantly lower than phagocytosis by self-adherent cells (not shown), indicating that the failure of undifferentiated U937 cells to phagocytose apoptotic targets was not a result of attachment to the substrate by polylysine. These effects were specific to PS-presenting target cells. Even though undifferentiated U937 cells were incapable of phagocytosing apoptotic thymocytes, they did phagocytose fluorescent latex beads, and no change in uptake of these targets occurred upon differentiation (data not shown).
These results indicate that PS exposure and the ability to phagocytose apoptotic cells appear at roughly the same time after induction of U937 cells with PMA. To determine whether the exposed PS on U937 cells was required for apoptotic cell engulfment, as is true for other macrophages [8] , phagocytosis by PMA-treated U937 cells was measured after pretreatment of either the target cell or phagocyte with annexin V. To ensure that annexin V was bound only to the pretreated cell type, cells were washed following pretreatment to remove excess unbound annexin V; in addition, Ca 2ϩ was kept at 2.5 mM during pretreatment, subsequent washes and phagocytosis to maintain strong annexin V binding to the pretreated cells, thus minimizing any possible exchange to unpretreated cells. After either one day (Fig. 5A ) or two days (Fig. 5B ) of PMA treatment, phagocytosis was substantially inhibited when either apoptotic thymocytes or U937 cells were pretreated with annexin V. Again, the effect was specific to PS-presenting target cells, as phagocytosis of latex beads was not inhibited by annexin V (data not shown), consistent with results for other macrophages [8] . As zVAD-fmk was not able to block the expression of PS on differentiating U937 cells, it was also unable to block the cells' ability to phagocytose apoptotic thymocytes (Fig. 5C ).
Differentiated U937 cells utilize CD14 for phagocytosis of apoptotic thymocytes
Phagocytosis of apoptotic cells requires protein receptors, as well as the expression of PS on macrophages. One such protein is the LPS receptor, CD14, as indicated by the ability of the anti-CD14 mAb 61D3 to inhibit phagocytosis of apoptotic lymphocytes [5, [22] [23] [24] . The expression of CD14 on U937 cells was monitored using four different monoclonal antibodies to CD14 (see Materials and Methods), all yielding similar results (not shown). Expression on undifferentiated U937 cells is low and not significantly increased until two days post-treatment with PMA. Nonetheless, phagocytosis was inhibited by 61D3 mAb, an anti-CD14 antibody shown to inhibit specifically the phagocytosis of apoptotic cells by macrophages [5, [25] [26] [27] , after only one day of PMA treatment (not shown).
PS is also expressed on U937 cells induced to differentiate by Vitamin D3 and retinoic acid
To determine whether surface expression of PS is a general feature of differentiation, rather than a specific effect of treatment with PMA, the effects of other inducers on PS expression were examined. VitD3 and t-RA are lipophilic agents that induce growth arrest and differentiation of a variety of cell types. When U937 cells are treated with each of these structurally disparate molecules, they respond in different ways. Cells treated with VitD3 for 3 days have been reported to become adherent, form aggregates, and express CD14 [28] . On the other hand, cells exposed to t-RA for 3 days do not display these characteristics, but instead express the low affinity IgE receptor CD23, the ␣6 integrin CD49f, and the biliary glycoprotein CD66a [28 -30] . Treatment with either agent increases the expression of Mac-1 [31] , and importantly, cotreating U937 cells with both VitD3 and t-RA potentiates the effects of either agent alone [32] .
When U937 cells were treated with either VitD3 or t-RA alone, neither increased adherence, nor was aggregation observed. However, when the cells were cotreated with VitD3 and t-RA, they became more adherent (although not as tenaciously as when treated with PMA) and formed aggregates. VitD3 alone induced increased expression of CD14, whereas t-RA alone did not (not shown). As expected, either agent alone induced increased expression of Mac-1, an increase that was detectable as early as 3 days of treatment (not shown) but maximal at 7 days, while cotreatment with both agents produced dramatically increased levels at 7 days (Fig. 6A) . To measure PS expression cells were stained with annexin V. After gating out apoptotic and dead cells by both light scatter and PI staining, the remaining viable cells showed little increase in annexin binding after 3 days of treatment with either VitD3 or t-RA, alone or in combination (not shown). After 7 days, treatment with either VitD3 or t-RA alone still produced little discernible increase, whereas dual treatment with VitD3 and t-RA produced a 1.5-fold increase in median fluorescence (Fig. 6B) , similar to that seen after one day of treatment with PMA. Phagocytosis assays were performed to test whether the appearance of PS is associated with the development of the ability to phagocytose apoptotic cells. As before, polylysinecoated coverslips were used to ensure attachment of both treated and untreated U937 cells. When cells treated with VitD3 and/or t-RA for 3 days were presented with apoptotic thymocytes, phagocytosis was no greater than by untreated U937 cells (not shown). At day 7, phagocytosis by cells treated with either agent alone was marginally increased or not increased at all, depending on the experiment (Fig. 7) . However, cells cotreated with VitD3 and t-RA for 7 days demonstrated a marked increase in the ability to phagocytose apoptotic thymocytes (Fig. 7) . If annexin V was included during phagocytosis (Fig. 7A) or if U937 cells were pretreated with annexin V (Fig. 7B) , phagocytosis was substantially inhibited, indicating that cell surface expression of PS on the differentiated U937 cells was a requirement for phagocytosis.
PS is expressed on primary monocyte-derived macrophages
To confirm these conclusions drawn from the U937 model system, similar experiments were carried out with primary
cell fractions maintain an asymmetric distribution of phospholipids [12] and monocytes in whole blood preparations are not stained by annexin V [13] , few monocytes are stained with annexin V (Fig. 8A) . Upon culturing, adherent monocytes undergo terminal differentiation to macrophages [16] . After 9 days in culture, cells were detached and analyzed. Some cells that retained the FS and SS characteristics of freshly isolated monocytes were not stained by annexin V (data not shown) and were gated out of profiles. Also gated out were all cells staining positive with PI, including lysed, late apoptotic cells. As shown in Fig. 8B , the remaining monocytederived macrophages were stained by annexin V, much as differentiated U937 cells.
PS is necessary for phagocytosis of apoptotic thymocytes by monocyte-derived macrophages
The ability of freshly isolated primary monocytes and monocyte-derived macrophages to phagocytose apoptotic thymocytes was also examined. Freshly isolated (2 h, adherent) monocytes did not phagocytose apoptotic thymocytes to a greater extent 7 . Phagocytosis of apoptotic thymocytes by U937 cells treated with VitD3 and/or t-RA to differentiate following pretreatment with annexin V. Untreated (nonapoptotic) murine thymocytes or thymocytes treated with dexamethasone to undergo apoptosis were presented to monolayer cultures of U937 cells that were treated for 7 days with VitD3 and/or t-RA. In one experiment, (A) annexin V was present during phagocytosis assays. In a separate experiment, (B) U937 cells were pretreated with annexin V (and washed) prior to phagocytosis assays. than nonapoptotic thymocytes (Fig. 9) . However, after allowing the monocytes to differentiate into macrophages, cells acquired the ability to preferentially phagocytose apoptotic thymocytes. Phagocytosis by these macrophages was largely inhibited when they were pretreated with annexin V, confirming that PS expression on the surface of differentiated primary macrophages is instrumental in phagocytosis of apoptotic thymocytes.
DISCUSSION
Macrophages are unique in constitutively expressing PS on their surface. One of the goals of the present study was to ask whether acquisition of surface PS could be counted among the numerous other morphological and functional alterations that accompany maturation of monocytes to macrophages. Several criteria were used to establish that PMA or VitD3 and t-RA were inducing differentiation of U937 cells and that these cells share phenotypic and functional properties with primary monocytes and macrophages. Morphologically, U937 cells treated for 1 or 2 days with PMA or for 7 days with VitD3 and t-RA maturated to a more macrophage-like phenotype. In addition, these treatments induced an increase in surface expression of CD11b and CD14, markers of macrophage differentiation [22] .
The results presented here show that, like circulating monocytes [12] , untreated, nonadherent U937 cells do not express PS on their surface. However, upon induction of differentiation by PMA or VitD3 and t-RA, U937 cells do display PS on their surface, like terminally differentiated macrophages [8] . Since surface expression of PS is a universal feature of cells undergoing apoptosis [33] , the report that PMA treatment of U937 cells induces other events characteristic of apoptosis, including chromatin condensation and DNA degradation [17] , raised the possibility that PS expression on U937 cells was part of an apoptotic program. The observation that the events characteristic of apoptosis were sensitive to inhibition by zVAD-fmk further suggested that differentiation to the macrophage phenotype might depend on caspase activation as apoptosis does. As shown here, zVAD-fmk is an efficient inhibitor of all aspects of apoptosis induced by CAM, including PS exposure. Similarly, when cells were treated with PMA, the DNA degradation observed was efficiently blocked by zVAD-fmk, as previously reported [17] . The amount of DNA degraded was low, however, and consistent with the possibility that it originates from a small subpopulation of cells undergoing apoptosis within the larger, differentiating population.
In marked contrast, however, zVAD-fmk does not prevent alterations characteristic of differentiation to macrophages. The morphological changes seen when U937 cells are treated with PMA were not prevented by zVAD-fmk. The expression of Mac-1 was similarly insensitive to this inhibitor, indicating that inhibiting caspases has no effect on differentiation. Therefore, the finding that zVAD-fmk did not block PMA induction of PS expression, unlike the case when PS expression was induced by CAM, suggests that the former occurs as part of the differentiation, rather than apoptosis, program. In addition, PS exposure on differentiating cells was much less extensive than on the same cells undergoing apoptosis and occurred on a much different timescale. Together, these results argue that surface expression of PS is a functional marker for monocyteϪmacrophage differentiation in U937 cells.
While this manuscript was in revision, Sordet et al. [34] reported that several caspases are activated when U937 cells treated with PMA or human primary monocytes differentiate to macrophages. However, despite caspase activation, a variety of assays indicated that the bulk population was not undergoing apoptosis and no more than 4% of the cells were morphologically apoptotic, in good agreement with our results. When cells were treated with a 10-fold higher concentration (100 M) of zVAD-fmk than was used in our study, nonapoptotic cell death and lysis occurred, obscuring whether this higher concentration could prevent differentiation. In contrast to our results, the investigators reported that after one day of treatment with PMA, U937 cells were not labeled by annexin V, based on the lack of a distinct subpopulation with increased staining. However, the subtle 1.5-fold increase in staining of the population as a whole on day one that we report might well go unnoticed.
Together, these studies demonstrate that such events as caspase activation and PS exposure normally associated with apoptosis can also be hallmarks of differentiation, independent of apoptosis.
It should be noted that PS exposure has also been described as part of the activation or differentiation of other cell types. In addition to the classic case of activated platelets [35] , it has been known for some years that activation of leukocytes can lead to transient expression of PS on the cell surface [12, 36 -38] . In addition, studies with whole animals suggest that the same is true for megakaryocytes prior to their fragmentation into platelets [33] , and both whole animal and in vitro studies indicate that myoblasts also expose PS prior to fusion to myotubes [33, 39] . As in the case of differentiating U937 cells, exposure of PS on fusing myoblasts does not depend on Fig. 9 . Phagocytosis of apoptotic thymocytes by primary human monocytes and differentiated, monocyte-derived macrophages following pretreatment with annexin V. Untreated (nonapoptotic) murine thymocytes or thymocytes treated with dexamethasone to undergo apoptosis were presented to monolayer cultures of freshly isolated human monocytes (day 0) or differentiated, monocytederived macrophages (day 11). Macrophages (M) were pretreated with 10 M annexin V (AV) for 15 min and washed twice to remove excess annexin V before targets were presented to them. The data presented are representative of two different experiments with similar results.
caspases [39] , arguing that neither of these two cases is a mistaken instance of apoptosis, or is a simple adaptation of the apoptotic pathway to new purposes. The functional consequences of PS exposure differ in these several cases. On activated platelets, PS provides a surface for assembling protease complexes [40] ; on myoblasts, and perhaps megakaryocytes, it is required for membrane fusion; on activated leukocytes, it may function in cell signaling; and as shown here, on differentiating monocytes (and their apoptotic targets), PS exposure is required for phagocytosis. It will be interesting to learn whether there is a common mechanistic thread that unites these disparate functions.
In several of the cases mentioned above, PS exposure is either transient or reversible, but the PS expression on macrophages is clearly not transient in nature, and is persistent once induced. This is also the case for primary peritoneal macrophages and the J774 macrophage cell line that constitutively express PS, which is required for phagocytosis of apoptotic cells [8] . Little is known of the mechanisms responsible for expression of PS on macrophages, which are activated upon differentiation. Presumably, exposure of PS on differentiating U937 cells requires down-regulation of the aminophospholipid translocase activity that normally restricts PS to the internal leaflet, and up-regulation of a scramblase activity to bring PS to the surface, as is the case in activated platelets and apoptotic cells [2, 3] . Testing this presumption may be difficult, given that the low level of PS exposure observed here would not require large-scale or global regulation of these activities. Another protein, the ABC1 or ced-7 ABC ATPase, has been implicated in PS externalization [11] , and this protein is upregulated during monocyte/macrophage differentiation [41] . Whether up-regulation of ABC1 expression contributes to the appearance of PS on U937 cells is currently under investigation.
A second primary goal of these studies was to establish the functionality of PS expression, that is, its requirement for phagocytosis of apoptotic cells. Expression of PS on differentiating U937 cells after one day of PMA treatment or 7 days of treatment with VitD3/t-RA was accompanied by the development of their ability to phagocytose apoptotic cells. Development of this capacity is specific for apoptotic targets, as undifferentiated U937 cells are already capable of phagocytosis per se. PS expression is specifically required for phagocytosis of apoptotic targets, since using annexin V to mask PS on the surface of differentiated U937 cells and primary monocytederived macrophages compromises their ability to phagocytose apoptotic targets, but has no effect on phagocytosis of latex beads, as previously shown with other macrophages [8] . Importantly, both PS expression and the ability to phagocytose apoptotic cells were acquired by U937 cells using two different regimes to induce differentiation, indicating that these traits are not a peculiarity of induction by PMA and suggesting that their acquisition is a general feature of monocyte differentiation independent of the mode of induction. However, some variability was seen in the extent to which annexin inhibited phagocytosis. For U937 cells treated for one day with PMA and for primary monocytes differentiated to macrophages, inhibition was nearly quantitative. However, for U937 cells treated for two days with PMA or treated with VitD3 and t-RA, inhibition was only partial. These results suggest that there may be mechanisms for recognizing and phagocytosing apoptotic cells that operate independently of PS expression on macrophages and are variably expressed depending on the mode of induction or extent of differentiation.
CD14 has previously been shown to be necessary for macrophages to phagocytose apoptotic lymphocytes [5, [25] [26] [27] . In the present study, treating U937 cells for one day with PMA did not induce a noticeable increase in CD14 expression as detected by immunofluorescence and flow cytometry. Still, mAb 61D3, specific for CD14, effectively inhibited phagocytosis of apoptotic cells by U937 cells treated with PMA for one day, suggesting that low level expression of CD14 on U937 cells is sufficient for phagocytic recognition. Interestingly, resonance energy transfer has been used to show that Mac-1 interacts with CD14 in the presence of LPS binding protein or serum upon LPS activation of neutrophils [42] . Furthermore, it has been suggested that ␤2 integrins, such as Mac-1, may serve as "promiscuous signal transduction devices" for GPIlinked receptors such as CD14 [43] . The increase in Mac-1 expression observed here may thus facilitate the successful involvement of a small number of cell surface CD14 molecules in the uptake of apoptotic cells. PS expression may facilitate such cooperation among macrophage receptors, for example by allowing receptors to rearrange on the cell surface, as has been proposed for ligands on apoptotic target cells [9] .
As shown in the present study, the ability to phagocytose apoptotic cells also requires the development of low levels of PS on the macrophage surface. This feature of monocyte differentiation is a gateway that allows macrophages to achieve an alternative phenotype required for the resolution of inflammatory episodes [44] . When monocytes are recruited to sites of infection or tissue damage and differentiate into macrophages, they promote inflammation via secretion of proinflammatory cytokines. However, resolution of inflammation requires clearance of the apoptotic leukocytes that gave rise to the inflammatory response, as well as damaged apoptotic cells that were resident in tissues. As macrophages engage in phagocytosis of unlysed apoptotic cells, they actively suppress inflammatory mediator production. For example, when monocyte-derived macrophages phagocytose apoptotic neutrophils in vitro, the production of interleukin (IL)-1␤, IL-8, granulocyte macrophage colony-stimulating factor, and tumor necrosis factor-␣, as well as leukotriene C-4 and thromboxane B2, is inhibited. In contrast, production of transforming growth factor-␤1, prostaglandin E2, and platelet-activating factor increases, inhibiting proinflammatory cytokine production [45] . These effects can also occur in vivo. When apoptotic cells are instilled into LPS-stimulated lungs of mice, reduced proinflammatory chemokine levels are seen in bronchoalveolar lavage fluid, and total inflammatory cell counts in the fluid are markedly reduced [46] . There is also evidence that clearance of apoptotic inflammatory cells is impaired in persistent inflammatory responses such as that seen in cystic fibrosis airways [47] . Thus, acquisition of PS by differentiating monocytes and transition to an anti-inflammatory phenotype has profound pathophysiological consequences.
